| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.8 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.0082 | 0.8 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.0091 | 0.8 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.018 | 0.8 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.8 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.8 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.8 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | -0.0081 | 0.8 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.011 | 0.8 |